Nifty Healthcare Index

NSE: NFTHEALTHC

14763.90 26.65 (0.18%)

Near 52W High of ₹15108.80

NSE 17 Jul, 2025 3:31 PM (IST)

Nifty Healthcare Index PB	6.0
Nifty Healthcare Index PE	38.3
Nifty Healthcare Index DIV	0.6
Nifty Healthcare Index EPS	386.0

Nifty Healthcare Index News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Nifty Healthcare Index from all sources in a single place.

Laurus Labs Ltd.

17 Jul 2025, 11:46PM

821.50

-0.13%

Andhra okays 39,473 cr investment across 22 projects, 30k+ jobs ahead

Business Standard

The eighth State Investment Promotion Board of Andhra Pradesh headed by Chief Minister N Chandrababu Naidu on Thursday approved 22 projects worth Rs 39,473 crore with the scope to generate 30,899 jobs, the government said. The CM directed ministers and officials to create the relevant ecosystem around the industrial projects coming up in the state. "The eighth SIPB headed by CM Chandrababu approved investments worth Rs 39,473 crore. The 22 projects approved today will provide jobs to 30,899 people," an official release said. The approved projects included an investment of Rs 1,800 crore from Renew Vyoman Power Pvt Ltd in Kurnool and Nandyal districts, JSW Neo Energy (Rs 2,000 crore; Kadapa), JSW AP Steel Plant (Rs 4,500 crore; Kadapa) and Laurus Labs (Rs 5,630 crore; Anakapalli). Other projects included Lulu Shopping Malls International Ltd (Rs 1,222 crore; Vizag & Vijayawada), Renew Photovoltaic (Rs 3,700 crore; Anakapalli) and AS International (Rs 1,000 crore; Chittoor), among ..

Laurus Labs Ltd. has an average target of 640.25 from 4 brokers.

Glenmark Pharmaceuticals Ltd.

17 Jul 2025, 11:13PM

2226.70

0.99%

Glenmark Pharma Will Turn Cash Positive With AbbVie's Licensing Deal: SP

NDTV Profit

Glenmark, through wholly-owned subsidiary IGI Therapeutics SA, announced an exclusive licensing agreement with AbbVie for ISB 2001.

Glenmark Pharmaceuti.. has an average target of 1601.25 from 5 brokers.

17 Jul 2025, 09:16PM

1955.70

1.33%

Company Update

Lupin Ltd - 500257 - Inspection Of U.S. FDA At The Company''s Pithampur Unit-3 Manufacturing Facility.

BSE India

Inspection of U.S. FDA at the Company''s Pithampur Unit-3 manufacturing facility.

17 Jul 2025, 09:08PM

1955.70

1.33%

Company Update

Lupin Ltd - 500257 - Inspection Of U.S. FDA At The Company''s Pithampur Unit-2 Manufacturing Facility.

BSE India

Inspection of U.S. FDA at the Company''s Pithampur Unit-2 manufacturing facility.

Syngene International Ltd.

17 Jul 2025, 08:32PM

670.40

0.40%

Company Update

Syngene International Ltd - 539268 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

Fortis Healthcare Ltd.

17 Jul 2025, 07:21PM

810.25

1.90%

Company Update

Fortis Healthcare Ltd - 532843 - Intimation On Tax Deduction At Source (TDS)/Withholding Tax On Dividend

BSE India

The relevant disclosure is attached.

Sun Pharmaceutical Industries Ltd.

17 Jul 2025, 06:14PM

1703.40

0.14%

Company Update

Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Intimation of incorporation of a subsidiary company in China.

17 Jul 2025, 05:59PM

1955.70

1.33%

Company Update

Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Lupin Achieves GMP Certification from TGA Australia for Dabhasa API Facility.

Mankind Pharma Ltd.

17 Jul 2025, 05:18PM

2639.30

0.53%

AGM

Mankind Pharma Ltd - 543904 - Intimation Of Dispatch Of Letter To Shareholders Whose E-Mail Addresses …

BSE India

Intimation of dispatch of Letter to Shareholder whose e-mail addresses are not registered with Company or Depositories

Mankind Pharma Ltd.

17 Jul 2025, 04:57PM

2639.30

0.53%

Company Update

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Advertisement for Intimation of 34th AGM and related information of Mankind Pharma Limited